|
1
|
Desai KI, Nadkarni TD, Goel A, Muzumdar
DP, Naresh KN and Nair CN: Primary Ewing's sarcoma of the cranium.
Neurosurgery. 46:62–68. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deokar K, Nana GK and Shivhari G: Primary
ewings sarcoma of the lung. J Clin Diagn Res. 9:XD01–XD03.
2015.PubMed/NCBI
|
|
3
|
de Alava E: Patología molecular de los
srcomas. Oncología (Barcelona). 28:22–38. 2005.(In Spain).
View Article : Google Scholar
|
|
4
|
Kumar N and Gupta B: Global incidence of
primary malignant bone tumors. Curr Orthopaedic Practice. 27:52016.
View Article : Google Scholar
|
|
5
|
Soto C, Gómez L, Criollo F, Romo R, Messa
Ó and Arbeláez P: Sarcoma de Ewing de la falange proximal del
meñique. Reporte de caso. Revista Colombiana de Cancerología.
18:137–142. 2014.(In Spain). View Article : Google Scholar
|
|
6
|
Dynamed, . Ewing sarcoma in children.
Available at:. https://www.dynamed.com/condition/ewing-sarcoma-in-children
|
|
7
|
Desai SS and Jambhekar NA: Pathology of
Ewing's sarcoma/PNET: Current opinion and emerging concepts. Indian
J Orthop. 44:363–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaneko Y, Kobayashi H, Handa M, Satake N
and Maseki N: EWS-ERG fusion transcript produced by chromosomal
insertion in a Ewing sarcoma. Genes Chromosomes Cancer. 18:228–231.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SK and Park YK: Ewing sarcoma: A
chronicle of molecular pathogenesis. Hum Pathol. 55:91–100. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balamuth NJ and Womer RB: Ewing's sarcoma.
Lancet Oncol. 11:184–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franzetti GA, Laud-Duval K, Bellanger D,
Stern MH, Sastre-Garau X and Delattre O: MiR-30a-5p connects
EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Oncogene. 32:3915–3921. 2012. View Article : Google Scholar
|
|
12
|
Matsumoto Y, Tanaka K, Nakatani F,
Matsunobu T, Matsuda S and Iwamoto Y: Downregulation and forced
expression of EWS-Fli1 fusion gene results in changes in the
expression of G(1)regulatory genes. Br J Cancer. 84:768–775. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Randall L, Calvert G, Spraker H, Lessnick
S and Sarcoma de Ewing: Diagnóstico, tratamiento y pronóstico.
Liddy Shriver Sarcoma Initiative. Available at:. http://sarcomahelp.org/translate/es-sarcoma-ewing.htmlJan
18–2018
|
|
14
|
Lawlor ER and Thiele CJ: Epigenetic
changes in pediatric solid tumors: Promising new targets. Clin
Cancer Res. 18:2768–2779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cavalheiro dos Santos D, da Cruz
Evangelista L and Kerche-Silva L: Genetic alterations and diagnosis
in Ewing sarcoma: A review. Oatext.com (2017). Available at:.
http://www.oatext.com/genetic-alterations-and-diagnosis-in-ewing-sarcoma-a-review.phpApr
5–2018
|
|
16
|
Parrish JK, Sechler M, Winn RA and
Jedlicka P: The histone demethylase KDM3A is a
microRNA-22-regulated tumor promoter in Ewing sarcoma. Oncogene.
34:257–262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rocchi A, Manara MC, Sciandra M, Zambelli
D, Nardi F, Nicoletti G, Garofalo C, Meschini S, Astolfi A, Colombo
MP, et al: CD99 inhibits neural differentiation of human Ewing
sarcoma cells and thereby contributes to oncogenesis. J Clin
Invest. 120:668–680. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Herreño AM, Fernández MJ, Rey L, Mejia JA,
Cañas A, Moreno OM, Henríquez B, Montecino MA and Rojas AP: Primary
lung cancer cell culture from transthoracic needle biopsy samples.
Cogent Med. 5:12018. View Article : Google Scholar :
|
|
19
|
Vural C, Uluoğlu O, Akyürek N, Oğuz A and
Karadeniz C: The evaluation of CD99 immunoreactivity and EWS/FLI1
translocation by fluorescence in situ hybridization in central
PNETs and Ewing's sarcoma family of tumors. Pathol Oncol Res.
17:619–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moorhead PS, Nowell PC, Mellman WJ,
Battips DM and Hungerford DA: Chromosome preparations of leukocytes
cultured from human peripheral blood. Exp Cell Res. 20:613–616.
1960. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McGowan-Jordan J, Simons A and Schmid M:
ISCN 2016. An International System for Human Cytogenomic
Nomenclature (2016). Karger; Basel: 2016, View Article : Google Scholar
|
|
22
|
Elzi DJ, Song M, Houghton PJ, Chen Y and
Shiio Y: The role of FLI-1-EWS, a fusion gene reciprocal to
EWS-FLI-1, in Ewing sarcoma. Genes Cancer. 6:452–461.
2015.PubMed/NCBI
|
|
23
|
Przybyl J, Kozak K, Kosela H, Falkowski S,
Switaj T, Lugowska I, Szumera-Cieckiewicz A, Ptaszynski K,
Grygalewicz B, Chechlinska M, et al: Gene expression profiling of
peripheral blood cells: New insights into Ewing sarcoma biology and
clinical applications. Med Oncol. 31:1092014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abcam (2011). A-beginners-guide-to-ChIP.
Available at. http://docs.abcam.com/pdf/chromatin/A-beginners-guide-to-ChIP.pdfJan
22–2018
|
|
25
|
Jacques C, Lamoureux F, Baud'huin M,
Rodriguez Calleja L, Quillard T, Amiaud J, Tirode F, Rédini F,
Bradner JE, Heymann D and Ory B: Targeting the epigenetic readers
in Ewing Sarcoma inhibits the oncogenic transcription factor
EWS/Fli1. Oncotarget. 7:24125–24140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haring M, Offermann S, Danker T, Horst I,
Peterhansel C and Stam M: Chromatin immunoprecipitation:
Optimization, quantitative analysis and data normalization. Plant
Methods. 3:112007. View Article : Google Scholar : PubMed/NCBI
|
